Advertisement

Topics

China’s Fosun updates on $1.3bn takeover of Indian drugmaker Gland Pharma

19:00 EDT 1 Aug 2017 | Pharmaceutical Technology

Chinese firm Shanghai Fosun Pharmaceutical has extended the termination date for its $1.3bn proposal to acquire approximately 86.08% stake in Indian sterile injectables maker Gland Pharma on 26 September.

Original Article: China’s Fosun updates on $1.3bn takeover of Indian drugmaker Gland Pharma

NEXT ARTICLE

More From BioPortfolio on "China’s Fosun updates on $1.3bn takeover of Indian drugmaker Gland Pharma"

Quick Search
Advertisement